Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Saad

Showing results (81-90 of 161) with videos related to

Pageof 17
Sort By:
Anti-Cancer Drugs|July 19, 2001
Phase I trial of i.v. administered tirapazamine plus cyclophosphamideP M Hoff, E D Saad, F Ravandi-Kashani, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 16, 2017
Time to Review the Role of Surrogate End Points in Health Policy: State of the Art and the Way ForwardOriana Ciani, Marc Buyse, Michael Drummond, et al.
Nature Reviews. Drug Discovery|June 4, 2016
Use of surrogate end points in healthcare policy: a proposal for adoption of a validation frameworkOriana Ciani, Marc Buyse, Mike Drummond, et al.
Clinical Trials (London, England)|June 24, 2017
The impact of data errors on the outcome of randomized clinical trialsMarc Buyse, Pierre Squifflet, Elisabeth Coart, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 2, 2014
Disseminated histoplasmosis in allogeneic bone marrow transplant: a diagnosis not to be missedS Haydoura, J Wallentine, B Lopansri, et al.
Journal of the National Cancer Institute|June 23, 2018
Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better?Everardo D Saad, John R Zalcberg, Julien Péron, et al.
Revista Da Associacao Medica Brasileira (1992)|May 26, 2010
Potential economic impact of the 21-gene expression assay on the treatment of breast cancer in BrazilCarlos Eduardo Bacchi, Flavio Prisco, Filomena M Carvalho, et al.
The Medical Journal of Malaysia|March 30, 2024
A retrospective study of breathlessness supportive therapy on chronic refractory breathlessness in a palliative care unitK T Tay, N N Nik Isahak, N Kasinathan, et al.
Cancers|September 28, 2023
Trial Design for Cancer Immunotherapy: A Methodological ToolkitEverardo D Saad, Elisabeth Coart, Vaiva Deltuvaite-Thomas, et al.
BMC Medical Research Methodology|October 5, 2022
The case against censoring of progression-free survival in cancer clinical trials - A pandemic shutdown as an illustrationCorinne Jamoul, Laurence Collette, Elisabeth Coart, et al.
Pageof 17

Showing results (81-90 of 161) with videos related to

Sort By:
Pageof 17
Anti-Cancer Drugs|July 19, 2001
Phase I trial of i.v. administered tirapazamine plus cyclophosphamideP M Hoff, E D Saad, F Ravandi-Kashani, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 16, 2017
Time to Review the Role of Surrogate End Points in Health Policy: State of the Art and the Way ForwardOriana Ciani, Marc Buyse, Michael Drummond, et al.
Nature Reviews. Drug Discovery|June 4, 2016
Use of surrogate end points in healthcare policy: a proposal for adoption of a validation frameworkOriana Ciani, Marc Buyse, Mike Drummond, et al.
Clinical Trials (London, England)|June 24, 2017
The impact of data errors on the outcome of randomized clinical trialsMarc Buyse, Pierre Squifflet, Elisabeth Coart, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 2, 2014
Disseminated histoplasmosis in allogeneic bone marrow transplant: a diagnosis not to be missedS Haydoura, J Wallentine, B Lopansri, et al.
Journal of the National Cancer Institute|June 23, 2018
Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better?Everardo D Saad, John R Zalcberg, Julien Péron, et al.
Revista Da Associacao Medica Brasileira (1992)|May 26, 2010
Potential economic impact of the 21-gene expression assay on the treatment of breast cancer in BrazilCarlos Eduardo Bacchi, Flavio Prisco, Filomena M Carvalho, et al.
The Medical Journal of Malaysia|March 30, 2024
A retrospective study of breathlessness supportive therapy on chronic refractory breathlessness in a palliative care unitK T Tay, N N Nik Isahak, N Kasinathan, et al.
Cancers|September 28, 2023
Trial Design for Cancer Immunotherapy: A Methodological ToolkitEverardo D Saad, Elisabeth Coart, Vaiva Deltuvaite-Thomas, et al.
BMC Medical Research Methodology|October 5, 2022
The case against censoring of progression-free survival in cancer clinical trials - A pandemic shutdown as an illustrationCorinne Jamoul, Laurence Collette, Elisabeth Coart, et al.
Pageof 17